New Super-Vaccine for kids enters final testing phase

NCT ID NCT06838000

Summary

This study is testing a new vaccine designed to protect against more strains of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. It will compare the new vaccine to an existing one in about 1,268 healthy infants, children, and adolescents. The main goals are to see if the new vaccine is safe and if it triggers a strong immune response.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Site # 2330001

    Paide, Järvamaa, 72713, Estonia

  • Site # 2330002

    Tallinn, Harju, EE-10617, Estonia

  • Site # 2330003

    Tallinn, Harju, EE-10617, Estonia

  • Site # 2330004

    Tartu, 50708, Estonia

  • Site # 2330005

    Tartu, Tartu, 50106, Estonia

  • Site # 2330006

    Tallinn, Harju, 10117, Estonia

  • Site # 2330007

    Tallinn, Harju, 13619, Estonia

  • Site # 6160001

    Torun, 87-100, Poland

  • Site # 6160002

    Bydgoszcz, 85-048, Poland

  • Site # 6160003

    Częstochowa, Silesian Voivodeship, 42-200, Poland

  • Site # 6160004

    Bydgoszcz, 85-796, Poland

  • Site # 6160006

    Kłodzko, 57-300, Poland

  • Site # 6160007

    Warsaw, Masovian Voivodeship, 03-291, Poland

  • Site # 6160009

    Lodz, Lodskie, 91-341, Poland

  • Site # 7640001

    Pathum Thani, Thailand

  • Site # 7640002

    Hat Yai, Changwat Songkhla, 90112, Thailand

  • Site # 7640003

    Mueang Nonthaburi, Chiang Mai, 50200, Thailand

  • Site # 7640004

    Chiang Mai, 50200, Thailand

  • Site # 7640006

    Bangkok, 10400, Thailand

  • Site # 7640007

    Bangkok, 10400, Thailand

  • Site # 7640008

    Bangkok, 10270, Thailand

  • Site # 8400001

    Houston, Texas, 77065, United States

  • Site # 8400002

    Omaha, Nebraska, 68114, United States

  • Site # 8400003

    Sioux City, Iowa, 51106, United States

  • Site # 8400004

    Union City, Georgia, 30291, United States

  • Site # 8400007

    Hialeah, Florida, 33012, United States

  • Site # 8400008

    Paramount, California, 90723, United States

  • Site # 8400009

    Miami, Florida, 33166, United States

  • Site # 8400012

    Ridgeland, Mississippi, 39531, United States

  • Site # 8400014

    Melbourne, Florida, 32934, United States

  • Site # 8400016

    Miami, Florida, 33166, United States

  • Site # 8400017

    Stephenville, Texas, 76401, United States

  • Site # 8400018

    Biloxi, Mississippi, 39531, United States

  • Site # 8400021

    Fayetteville, Georgia, 30214, United States

  • Site # 8400023

    Erlanger, Kentucky, 41018, United States

  • Site # 8400024

    Doral, Florida, 33166, United States

  • Site # 8400025

    Rochester, New York, 14642, United States

  • Site #8400010

    Binghamton, New York, 13905, United States

Conditions

Explore the condition pages connected to this study.